Find Federal Grants
National Institutes of Health · RFA-HG-22-026
Domestic Violence Prevention Enhancement and Leadership Through Alliances (DELTA): Achieving Health Equity through Addressing Disparities (AHEAD)
Centers for Disease Control - NCIPC · CDC-RFA-CE23-2301
Health Resources and Services Administration · HRSA-23-078
HEAL Initiative: HEAL Data2Action Acceleration Projects (R33 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-23-058
HEAL Initiative: HEAL Data2Action Innovation and Acceleration Projects, Phased Awards (R61/R33, Clinical Trial Optional)
National Institutes of Health · RFA-DA-23-057
Ethiopia USAID-Addis Ababa · 72066322RFI000011
National Institutes of Health · RFA-AI-22-059
NIAID Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
National Institutes of Health · PAR-22-241
South Africa USAID-Pretoria · 72067422RFA00009
Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC) (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-22-029
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-23-039
Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-22-031
Data Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - DCC) (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-22-030
Health Resources and Services Administration · HRSA-23-004
Defense Health Agency Contracting Activity - DHACA · W81XWH-22-DHAPP
Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (UT1, UT2 Clinical Trail Not Allowed)
National Institutes of Health · RFA-TR-22-031
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
National Institutes of Health · RFA-MH-22-271
Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
National Institutes of Health · RFA-MH-22-270
Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (U43/U44 - Clinical Trail Not Allowed)
National Institutes of Health · RFA-TR-22-032
Large Scale Integrated Mapping and Molecular Profiling of Cell Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-23-035